MiMedx Group, Inc. (MDXG) Q4 2025 Earnings Call Transcript

SA Transcripts158.62K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call MiMedx Group, Inc. (MDXG) Q4 2025 Earnings Call February 25, 2026 4:30 PM EST Company Participants Matthew Notarianni - Head of Investor RelationsJoseph Capper - CEO & DirectorDouglas Rice - Chief Financial Officer Conference Call Participants David Turkaly - Citizens JMP Securities, LLC, Research DivisionChase Knickerbocker - Craig-Hallum Capital Group LLC, Research DivisionFrank Takkinen - Lake Street Capital Markets, LLC, Research DivisionBradley Bowers - Mizuho Securities USA LLC, Research Division Presentation Operator Good afternoon, and thank you for standing by. Welcome to the MiMedx Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. Matt Notarianni, Head of Investor Relations from MiMedx. Thank you, Matt. You may begin. Matthew NotarianniHead of Investor Relations Thank you, operator, and good afternoon, everyone. Welcome to the MiMedx Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call. With me on today's call are Chief Executive Officer, Joe Capper; and Chief Financial Officer, Doug Rice. As part of today's webcast, we are simultaneously displaying slides that you can follow. You can access the slides from the Investor Relations website at mimedx.com. Joe will kick us off with some opening remarks and a summary of our operating highlights as well as a discussion of the market environment and our financial goals. Next, Doug will provide a review of our financial results for the quarter and full year. Joe will then conclude before we make ourselves available for your questions. Before we begin, I would like to remind you that our comments today will include forward-looking statements, including statements regarding future sales, operating results and cash balance growth, future margins and expenses, our product portfolios and expected market sizes for our